TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,806,000 | +2.6% | 132,500 | +23.3% | 0.04% | -30.2% |
| Q3 2021 | $1,761,000 | -2.7% | 107,500 | 0.0% | 0.05% | -17.2% |
| Q2 2021 | $1,809,000 | -7.8% | 107,500 | 0.0% | 0.06% | +30.6% |
| Q1 2021 | $1,963,000 | +2057.1% | 107,500 | +2050.0% | 0.05% | +2350.0% |
| Q4 2020 | $91,000 | +2.2% | 5,000 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $89,000 | -1.1% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $90,000 | -96.0% | 5,000 | -95.5% | 0.01% | -97.3% |
| Q1 2019 | $2,272,000 | – | 111,550 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |